Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

State of the science of adherence in pre-exposure prophylaxis and microbicide trials.

Muchomba FM, Gearing RE, Simoni JM, El-Bassel N.

J Acquir Immune Defic Syndr. 2012 Dec 1;61(4):490-8. doi: 10.1097/QAI.0b013e31826f9962. Review.

PMID:
22932322
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

What's love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples.

Ware NC, Wyatt MA, Haberer JE, Baeten JM, Kintu A, Psaros C, Safren S, Tumwesigye E, Celum CL, Bangsberg DR.

J Acquir Immune Defic Syndr. 2012 Apr 15;59(5):463-8. doi: 10.1097/QAI.0b013e31824a060b.

PMID:
22267018
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Microbicide clinical trial adherence: insights for introduction.

Woodsong C, MacQueen K, Amico KR, Friedland B, Gafos M, Mansoor L, Tolley E, McCormack S.

J Int AIDS Soc. 2013 Apr 8;16:18505. doi: 10.7448/IAS.16.1.18505. Review.

PMID:
23561044
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness.

Amico KR.

Curr Opin HIV AIDS. 2012 Nov;7(6):542-8. doi: 10.1097/COH.0b013e3283582d4a. Review.

PMID:
22964887
[PubMed - indexed for MEDLINE]
5.

Oral antiretroviral chemoprophylaxis: current status.

Baeten J, Celum C.

Curr Opin HIV AIDS. 2012 Nov;7(6):514-9. doi: 10.1097/COH.0b013e3283582d30. Review.

PMID:
22964886
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women.

Minnis AM, Gandham S, Richardson BA, Guddera V, Chen BA, Salata R, Nakabiito C, Hoesley C, Justman J, Soto-Torres L, Patterson K, Gomez K, Hendrix CW.

AIDS Behav. 2013 Feb;17(2):737-47. doi: 10.1007/s10461-012-0333-8.

PMID:
23065145
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Use of antiretrovirals for HIV prevention: what do we know and what don't we know?

Baeten JM, Grant R.

Curr HIV/AIDS Rep. 2013 Jun;10(2):142-51. doi: 10.1007/s11904-013-0157-9. Review.

PMID:
23494772
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Acceptability in microbicide and PrEP trials: current status and a reconceptualization.

Mensch BS, van der Straten A, Katzen LL.

Curr Opin HIV AIDS. 2012 Nov;7(6):534-41. doi: 10.1097/COH.0b013e3283590632. Review.

PMID:
23032737
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Methodological lessons from clinical trials and the future of microbicide research.

van der Straten A, Montgomery ET, Hartmann M, Minnis A.

Curr HIV/AIDS Rep. 2013 Mar;10(1):89-102. doi: 10.1007/s11904-012-0141-9. Review.

PMID:
23184582
[PubMed - indexed for MEDLINE]
10.

Adherence support approaches in biomedical HIV prevention trials: experiences, insights and future directions from four multisite prevention trials.

Amico KR, Mansoor LE, Corneli A, Torjesen K, van der Straten A.

AIDS Behav. 2013 Jul;17(6):2143-55. doi: 10.1007/s10461-013-0429-9. Review.

PMID:
23435697
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Toward an information-motivation-behavioral skills model of microbicide adherence in clinical trials.

Ferrer RA, Morrow KM, Fisher WA, Fisher JD.

AIDS Care. 2010 Aug;22(8):997-1005. doi: 10.1080/09540121003623719.

PMID:
20552466
[PubMed - indexed for MEDLINE]
12.

High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya.

Van der Elst EM, Mbogua J, Operario D, Mutua G, Kuo C, Mugo P, Kanungi J, Singh S, Haberer J, Priddy F, Sanders EJ.

AIDS Behav. 2013 Jul;17(6):2162-72. doi: 10.1007/s10461-012-0317-8.

PMID:
23080358
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Acceptability of vaginal microbicides among female sex workers and their intimate male partners in two Mexico-US border cities: a mixed methods analysis.

Robertson AM, Syvertsen JL, Martinez G, Rangel MG, Palinkas LA, Stockman JK, Ulibarri MD, Strathdee SA.

Glob Public Health. 2013;8(5):619-33. doi: 10.1080/17441692.2012.762412. Epub 2013 Feb 12.

PMID:
23398385
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis.

Baeten J, Celum C.

Annu Rev Med. 2013;64:219-32. doi: 10.1146/annurev-med-050911-163701. Epub 2012 Sep 27. Review.

PMID:
23020883
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.

Long EF, Stavert RR.

J Gen Intern Med. 2013 Oct;28(10):1294-301. doi: 10.1007/s11606-013-2417-1. Epub 2013 Apr 16.

PMID:
23588668
[PubMed - indexed for MEDLINE]
16.

An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda.

Psaros C, Haberer JE, Katabira E, Ronald A, Tumwesigye E, Campbell JD, Wangisi J, Mugwanya K, Kintu A, Enyakoit M, Thomas KK, Donnell D, Krows M, Kidoguchi L, Ware N, Baeten JM, Celum C, Bangsberg DR, Safren SA.

J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):522-9. doi: 10.1097/QAI.0000000000000212.

PMID:
24853311
[PubMed - indexed for MEDLINE]
17.

Considerations regarding antiretroviral chemoprophylaxis in MSM.

Poynten IM, Zablotska I, Grulich AE.

Curr Opin HIV AIDS. 2012 Nov;7(6):549-56. doi: 10.1097/COH.0b013e3283582c71. Review.

PMID:
22918448
[PubMed - indexed for MEDLINE]
18.

Rectal microbicide development.

McGowan I.

Curr Opin HIV AIDS. 2012 Nov;7(6):526-33. doi: 10.1097/COH.0b013e3283582bc2. Review.

PMID:
23032732
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Attitudes towards new HIV biomedical prevention technologies among a cohort of HIV-negative gay men in Sydney, Australia.

Poynten IM, Jin F, Prestage GP, Kaldor JM, Imrie J, Grulich AE.

HIV Med. 2010 Apr;11(4):282-8. doi: 10.1111/j.1468-1293.2009.00777.x. Epub 2009 Dec 8.

PMID:
20015220
[PubMed - indexed for MEDLINE]
20.

Adherence to antiretroviral prophylaxis for HIV prevention: a substudy cohort within a clinical trial of serodiscordant couples in East Africa.

Haberer JE, Baeten JM, Campbell J, Wangisi J, Katabira E, Ronald A, Tumwesigye E, Psaros C, Safren SA, Ware NC, Thomas KK, Donnell D, Krows M, Kidoguchi L, Celum C, Bangsberg DR.

PLoS Med. 2013;10(9):e1001511. doi: 10.1371/journal.pmed.1001511. Epub 2013 Sep 10.

PMID:
24058300
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk